immune checkpoint inhibitors: recent progress and potential biomarkers - 2v immune cells
Published 1 year ago • 97 plays • Length 0:58Download video MP4
Download video MP3
Similar videos
-
8:17
immune checkpoint inhibitors
-
6:47
immunotherapy | advance cancer treatment | dr chakor vora
-
5:10
introduction to immune checkpoint inhibitor (ici) immunotherapy
-
0:35
immune checkpoint inhibitors: recent progress and potential biomarkers - 1i introduction
-
0:46
immune checkpoint inhibitors: recent progress and potential biomarkers - 1ii introduction
-
0:41
immune checkpoint inhibitors: recent progress and potential biomarkers - 6iii epigenetic signatures
-
0:38
immune checkpoint inhibitors: recent progress and potential biomarkers - 4ii neoantigens
-
0:58
immune checkpoint inhibitors: recent progress and potential biomarkers - 2iv immune cells
-
0:48
immune checkpoint inhibitors: recent progress and potential biomarkers - 4i neoantigens
-
0:58
immune checkpoint inhibitors: recent progress and potential biomarkers - 2ii immune cells
-
0:28
immune checkpoint inhibitors: recent progress and potential biomarkers - 6i epigenetic signatures
-
0:59
immune checkpoint inhibitors: recent progress and potential biomarkers - 2iii immune cells
-
0:58
immune checkpoint inhibitors: recent progress and potential biomarkers - 3iii pd-l1 overexpression
-
0:46
immune checkpoint inhibitors: recent progress and potential biomarkers - 3iv pd-l1 overexpression
-
0:46
immune checkpoint inhibitors: recent progress and potential biomarkers - 3i pd-l1 overexpression
-
0:43
immune checkpoint inhibitors: recent progress and potential biomarkers - 1v introduction
-
0:36
immune checkpoint inhibitors: recent progress and potential biomarkers - 3ii pd-l1 overexpression
-
0:45
immune checkpoint inhibitors: recent progress and potential biomarkers - 1iii introduction
-
0:35
immune checkpoint inhibitors: recent progress and potential biomarkers - 5ii genetic signatures
-
0:58
immune checkpoint inhibitors: recent progress and potential biomarkers - 4iii neoantigens